drugset
drugset / Trial / NCT03945539

A Study to Evaluate the Effect of Itraconazole on JNJ-56136379 in Healthy Adult Participants

NCT03945539 ↗

Phase 1 Completed 16 enrolled Janssen Sciences Ireland UC
NaSingle-groupOpen-labelOther

Summary

The main purpose of this study is to assess the effect of itraconazole at steady-state on a single-dose pharmacokinetic (PK) of JNJ-56136379 in healthy adult participants.

Timeline

Start
2019-05-15
Primary completion
2019-10-04
Completion
2019-10-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule 200 mg Oral
Subject bersacapavir Other / unclassified — Oral

Indications

No indication recorded.